Molecular cancer testing has found varying but increasing clinical adoption in the practice of cancer diagnostics and care. Often innovation outpaces clinical adoption. Full realization of the benefits of this rapidly advancing field requires more than adoption of testing but also the creation of a comprehensive precision oncology program.
Listen in as Stephen Gruber, Vice President at City of Hope National Medical Center and Director of City of Hope’s Center for Precision Medicine, Stacy Gray, Chief of City of Hope’s Division of Clinical Cancer Genomics and Deputy Director of its Center for Precision Medicine, Sumanta “Monty” Pal, Co-Director of the Kidney Cancer Program at City of Hope, and Rick Baehner, M.D., Chief Medical Officer at Exact Sciences Precision Oncology, describe their experience building their precision oncology program. They describe how the program has improved patient care and clinical outcomes along with how they transformed hurdles into opportunities during the program implementation — ultimately delivering benefits for patients and health care professionals.
View this recording to:
- Understand the clinical benefits of a broad scale precision oncology program
- Learn about the foreseeable implementation challenges and ways to successfully address them in proactive ways
- Be introduced to how precision oncology programs are benefiting the community of patients and healthcare professionals at City of Hope